24 May 2013
Keywords: pfizer, maraviroc, impresses, hiv, trials, usa-based, drug
Article | 12 March 2007
USA-based drug giant Pfizer says that 24-week data from a trial of its antiviral maraviroc indicate that nearly double the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 March 2007
23 May 2013
© 2013 thepharmaletter.com